Literature DB >> 20607589

In silico analysis of the histaprodifen induced activation pathway of the guinea-pig histamine H(1)-receptor.

Andrea Strasser1, Hans-Joachim Wittmann.   

Abstract

The binding of (partial) agonists in the binding pocket of biogenic amine receptors induces a conformational change from the inactive to the active state of the receptors. There is only little knowledge about the binding pathways of ligands into binding pocket on molecular level. So far, it was not possible with molecular dynamic simulations to observe the ligand binding and receptor activation. Furthermore, there is nearly nothing known, in which state of ligand binding, the receptor gets activated. The aim of this study was to get more detailed insight into the process of ligand binding and receptor activation. With the recently developed LigPath algorithm, we scanned the potential energy surface of the binding process of dimeric histaprodifen, a partial agonist at the histamine H(1)-receptor, into the guinea pig histamine H(1)-receptor, taking also into account the receptor activation. The calculations exhibited large conformational changes of Trp(6.48) and Phe(6.55) during ligand binding and receptor activation. Additionally, conformational changes were also observed for Phe(6.52), Tyr(6.51) and Phe(6.44). Conformational changes of Trp(6.48) and Phe(6.52) are discussed in literature as rotamer toggle switch in context with receptor activation. Additionally, the calculations indicate that the binding of dimeric histaprodifen, accompanied by receptor activation is energetically preferred. In general, this study gives new, theoretical insights onto ligand binding and receptor activation on molecular level.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20607589     DOI: 10.1007/s10822-010-9372-2

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  48 in total

1.  Constitutive activation of the beta2 adrenergic receptor alters the orientation of its sixth membrane-spanning segment.

Authors:  J A Javitch; D Fu; G Liapakis; J Chen
Journal:  J Biol Chem       Date:  1997-07-25       Impact factor: 5.157

Review 2.  Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.

Authors:  Kurt Kristiansen
Journal:  Pharmacol Ther       Date:  2004-07       Impact factor: 12.310

3.  A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6.

Authors:  Chris Oostenbrink; Alessandra Villa; Alan E Mark; Wilfred F van Gunsteren
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

Review 4.  G protein-coupled receptors. II. Mechanism of agonist activation.

Authors:  U Gether; B K Kobilka
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

5.  Ligand entry and exit pathways in the beta2-adrenergic receptor.

Authors:  Ting Wang; Yong Duan
Journal:  J Mol Biol       Date:  2009-08-06       Impact factor: 5.469

6.  Mutation of a single TMVI residue, Phe(282), in the beta(2)-adrenergic receptor results in structurally distinct activated receptor conformations.

Authors:  Songhai Chen; Fang Lin; Ming Xu; R Peter Riek; Jiri Novotny; Robert M Graham
Journal:  Biochemistry       Date:  2002-05-14       Impact factor: 3.162

7.  Molecular basis for the selective interaction of synthetic agonists with the human histamine H1-receptor compared with the guinea pig H1-receptor.

Authors:  Andrea Strasser; Hans-Joachim Wittmann; Marc Kunze; Sigurd Elz; Roland Seifert
Journal:  Mol Pharmacol       Date:  2008-12-01       Impact factor: 4.436

8.  Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation.

Authors:  Supriyo Bhattacharya; Spencer E Hall; Hubert Li; Nagarajan Vaidehi
Journal:  Biophys J       Date:  2007-12-07       Impact factor: 4.033

9.  Mutational analysis of the histamine H1-receptor binding pocket of histaprodifens.

Authors:  Martijn Bruysters; Heinz H Pertz; Aloys Teunissen; Remko A Bakker; Michel Gillard; Pierre Chatelain; Walter Schunack; Henk Timmerman; Rob Leurs
Journal:  Eur J Pharmacol       Date:  2004-03-08       Impact factor: 4.432

10.  N(alpha)-imidazolylalkyl and pyridylalkyl derivatives of histaprodifen: synthesis and in vitro evaluation of highly potent histamine H(1)-receptor agonists.

Authors:  Sonja Menghin; Heinz H Pertz; Kai Kramer; Roland Seifert; Walter Schunack; Sigurd Elz
Journal:  J Med Chem       Date:  2003-12-04       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.